Pradžia › Minkštųjų audinių sarkoma › New York
Minkštųjų audinių sarkoma klinikiniai tyrimai New York
27 tyrimai dėl Minkštųjų audinių sarkoma ieško dalyvių vietose New York.
Miestai New York
- New York City19 tyrimai
- Queens9 tyrimai
- Greenburgh7 tyrimai
- Staten Island6 tyrimai
- New Rochelle6 tyrimai
- The Bronx3 tyrimai
Oficialus tyrimo tekstas (anglų kalba)
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-02 · NCT06942442Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069A Study of CRD3874-SI in People With Solid Tumors
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ir dar 1
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-21 · NCT06021626First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-11 · NCT06797999Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai1 fazė
Amžius nuo 12 iki 85 · Visoms lytims · Atnaujinta 2026-09-08 · NCT03715933Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- New York University Langone Health, New York
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT05732831Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-08 · NCT04577014First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT06644755Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
- Montefiore Medical Center, The Bronx
Renkami dalyviai1/2 fazė
Amžius nuo 12 iki 40 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07725380A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ir dar 1
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT05837767Actinium Therapy for Late-stage Aggressive Sarcomas
- Memorial Sloane Kettering Cancer Center, New York
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-28 · NCT07156565STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
- Northwell Health Cancer Institute, Lake Success
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT06975293Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- Roswell Park Cancer Institute, Buffalo
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-21 · NCT03965234A Study of MGC026 in Participants With Advanced Solid Tumors
- START-New York Long Island, Lake Success
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-11 · NCT06242470Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- Memorial Sloan Kettering Commack (Consent and Follow-Up), Commack
- Memorial Sloan Kettering Westchester (Consent and Followup), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ir dar 1
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-07-30 · NCT00579566A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
- Memorial Sloan Kettering Cancer Center Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ir dar 1
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-28 · NCT07089992Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors
- Zai Lab Site 02002, New York
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-23 · NCT07374848Integrated Cancer Repository for Cancer Research
- C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
- Faxton St. Luke's Healthcare, Mohawk Valley, Utica
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 19 iki 110 · Visoms lytims · Atnaujinta 2026-06-29 · NCT02012699Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ), Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
- ir dar 1
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-15 · NCT06129903A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg
- Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- ir dar 1
Renkami dalyviai2 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-04-23 · NCT04332874Brief Title Mechanisms of Cancer-Related Pain and Opioid Use Among Adolescents and Young Adult Sarcoma Survivors: Pilot Feasibility Study
- Roswell Park Comprehensive Cancer Center, Buffalo
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 12 iki 70 · Visoms lytims · Atnaujinta 2026-04-15 · NCT07402577A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
- Memorial Sloan Kettering Cancer Centre, New York
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-12 · NCT05755113Phase II Trial of Lung Chemoemobolization
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-05 · NCT05672108Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
- New York Medical Center/ Maria Fareri Children's Hospital, Valhalla
Renkami dalyviai1/2 fazė
12 Months – 40 Years · Visoms lytims · Atnaujinta 2026-02-05 · NCT03465592Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
Renkami dalyviai1/2 fazė
Amžius nuo 2 iki 30 · Visoms lytims · Atnaujinta 2026-02-03 · NCT05734066A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital at Montefiore, The Bronx
Renkami dalyviai2 fazė
18 Months – 40 Years · Visoms lytims · Atnaujinta 2025-08-12 · NCT05135975A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
- Memorial Sloan-Kettering Cancer Center, New York
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2024-11-25 · NCT05824975Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.